- BrandJ & J
Contain : Trabectadin
Company : J & J
Availability : 1mg Injection
Yondelis by Jhonson & Jhonson Pharmaceutical contain Trabectedin.
Yondelis is indicated for treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen
The reccomended dose of YONDELIS Chemotherapy is 1.5 mg/m2 administered as an intravenous infusion over 24 hours through a central venous line once every 21 days (3 weeks), until disease progression or unacceptable toxicity.
Yondelis therapy is contraindicated severe hypersensitivity, including anaphylaxis, to trabectedin.
Yondelis should be storage at 2C to 8C. in refrigerator.
K M Healthcare is supplier of Yondelis injection at very economical and very affordable price.